摘要 |
This invention is concerned with compounds of the formula (I) wherein X, A, B, R<SUP>1</SUP>, R<SUP>2</SUP> and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to then- use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5. |
申请人 |
F. HOFFMANN-LA ROCHE AG;BINGGELI, ALFRED;CHRIST, ANDREAS, D.;GREEN, LUKE;GUBA, WOLFGANG;MAERKI, HANS, P.;MARTIN, RAINER, E.;MOHR, PETER |
发明人 |
BINGGELI, ALFRED;CHRIST, ANDREAS, D.;GREEN, LUKE;GUBA, WOLFGANG;MAERKI, HANS, P.;MARTIN, RAINER, E.;MOHR, PETER |